Cargando…
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539466/ https://www.ncbi.nlm.nih.gov/pubmed/35716015 http://dx.doi.org/10.1111/dth.15645 |
_version_ | 1784803494357630976 |
---|---|
author | Molinelli, Elisa Sapigni, Claudia Simonetti, Oriana Radi, Giulia Gambini, Daisy Maurizi, Andrea Rizzetto, Giulio D'Agostino, Giovanni Marco Offidani, Annamaria |
author_facet | Molinelli, Elisa Sapigni, Claudia Simonetti, Oriana Radi, Giulia Gambini, Daisy Maurizi, Andrea Rizzetto, Giulio D'Agostino, Giovanni Marco Offidani, Annamaria |
author_sort | Molinelli, Elisa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9539466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95394662022-10-14 Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa Molinelli, Elisa Sapigni, Claudia Simonetti, Oriana Radi, Giulia Gambini, Daisy Maurizi, Andrea Rizzetto, Giulio D'Agostino, Giovanni Marco Offidani, Annamaria Dermatol Ther Letters John Wiley & Sons, Inc. 2022-06-28 2022-08 /pmc/articles/PMC9539466/ /pubmed/35716015 http://dx.doi.org/10.1111/dth.15645 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters Molinelli, Elisa Sapigni, Claudia Simonetti, Oriana Radi, Giulia Gambini, Daisy Maurizi, Andrea Rizzetto, Giulio D'Agostino, Giovanni Marco Offidani, Annamaria Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
title | Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
title_full | Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
title_fullStr | Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
title_full_unstemmed | Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
title_short | Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
title_sort | successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539466/ https://www.ncbi.nlm.nih.gov/pubmed/35716015 http://dx.doi.org/10.1111/dth.15645 |
work_keys_str_mv | AT molinellielisa successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT sapigniclaudia successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT simonettioriana successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT radigiulia successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT gambinidaisy successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT mauriziandrea successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT rizzettogiulio successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT dagostinogiovannimarco successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa AT offidaniannamaria successfullyandsafetyuseofdupilumabinthemanagementofsevereatopicdermatitisandconcomitantmoderatetoseverehidradenitissuppurativa |